{"entity":{"type":"insider","cik":"0001746274","url":"/insider/0001746274","json_url":"/insider/0001746274.json","name":"Catalys Pacific Fund, LP","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":4,"first":"2023-02-16","last":"2025-11-21","span_basis":"filed_date"},"name_variants":[{"name":"Catalys Pacific Fund, LP","source":"filing","n_filings":4,"first_seen":"2023-02-16","last_seen":"2025-11-21"}],"transactions":[{"id":4857590,"accession":"0001933414-25-000156","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001933414-25-000156","line_url":"/filing/0001933414-25-000156#line-1","is_derivative":false,"issuer_cik":"0001746274","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001746274","owner_cik":null,"owner_name":"Catalys Pacific Fund, LP; Slingsby Brian Taylor","owner_display_name":"Catalys Pacific Fund, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000000.0,"shares_display":"1,000,000","price_per_share":43.35,"price_display":"43.35","price_state":"stated","total_value":43350000.0,"total_display":"43,350,000.00","total_whole":"43,350,000","shares_owned_after":7903838.0,"shares_owned_after_display":"7,903,838","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-20","filed_date":"2025-11-21","scope":"insider"},{"id":5180477,"accession":"0001933414-25-000052","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001933414-25-000052","line_url":"/filing/0001933414-25-000052#line-1","is_derivative":false,"issuer_cik":"0001746274","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001746274","owner_cik":null,"owner_name":"Catalys Pacific Fund, LP; Slingsby Brian Taylor","owner_display_name":"Catalys Pacific Fund, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":259259.0,"shares_display":"259,259","price_per_share":13.5,"price_display":"13.50","price_state":"stated","total_value":3499996.5,"total_display":"3,499,996.50","total_whole":"3,499,997","shares_owned_after":8903838.0,"shares_owned_after_display":"8,903,838","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-13","filed_date":"2025-04-25","scope":"insider"},{"id":3059117,"accession":"0001628280-24-033205","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-24-033205","line_url":"/filing/0001628280-24-033205#line-1","is_derivative":false,"issuer_cik":"0001746274","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001746274","owner_cik":null,"owner_name":"Slingsby Brian Taylor; Catalys Pacific Fund, LP","owner_display_name":"Slingsby Brian Taylor","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":550000.0,"shares_display":"550,000","price_per_share":13.05,"price_display":"13.05","price_state":"stated","total_value":7177500.0,"total_display":"7,177,500.00","total_whole":"7,177,500","shares_owned_after":8644579.0,"shares_owned_after_display":"8,644,579","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-07-24","filed_date":"2024-07-26","scope":"insider"},{"id":7982821,"accession":"0001628280-23-003922","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-23-003922","line_url":"/filing/0001628280-23-003922#line-2","is_derivative":false,"issuer_cik":"0001746274","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001746274","owner_cik":null,"owner_name":"Catalys Pacific Fund, LP; Slingsby Brian Taylor","owner_display_name":"Catalys Pacific Fund, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250000.0,"shares_display":"250,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":4000000.0,"total_display":"4,000,000.00","total_whole":"4,000,000","shares_owned_after":9194579.0,"shares_owned_after_display":"9,194,579","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-02-14","filed_date":"2023-02-16","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001933414","name":"Mineralys Therapeutics, Inc.","url":"/issuer/0001933414","role":"Ten percent owner","n_filings":4,"first_seen":"2023-02-16","last_seen":"2025-11-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001746274","retrieved_at":"2026-08-24T07:56:06+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}